P137: The oxido-reductases enzymes (TDO2 and SOD2) in colonic mucosa are markers associated with histological activity and clinical course in ulcerative colitisECCO '16 Amsterdam
2016
P138: Results of dysplasia surveillance programme with chromoendoscopy for inflammatory bowel disease: do we have to biopsy all lesions?ECCO '16 Amsterdam
2016
P139: Gut bacterial DNA translocation is an independent risk factor of flare in the short term in patients with Crohn’s disease (ADATHEC study)ECCO '16 Amsterdam
2016
P140: Biopsies taken from mucosa surrounding dysplastic lesions found during IBD surveillance show a low rate of dysplasiaECCO '16 Amsterdam
2016
P141: Comparison of diagnostic accuracy of videocapsule endoscopy and CT/MR enterography in patients with established small bowel Crohn’s diseaseECCO '16 Amsterdam
2016
P142: Second-generation colon capsule endoscopy (C2) is highly accurate to detect mucosal lesions: a prospective study in over 100 patients with ulcerative colitisECCO '16 Amsterdam
2016
P143: Quality in inflammatory bowel disease care: measure, educate, and improve—a real-life surveyECCO '16 Amsterdam
2016
P144: TNF-inhibitor use and efficacy in upper-GI Crohn’s disease: results from a multicentre retrospective studyECCO '16 Amsterdam
2016
P145: Migraine is the most frequent extra-intestinal manifestation in patients with inflammatory bowel diseaseECCO '16 Amsterdam
2016
P146: Risk factors of clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.ECCO '16 Amsterdam
2016
P147: The valuation of the Short Inflammatory Bowel Disease Questionnaire for use in economic evaluationsECCO '16 Amsterdam
2016
P149: Intestinal perfusion measurements with contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging enterography: A comparison studyECCO '16 Amsterdam
2016
P150: Zinc deficiency is associated with increased disease-related morbidity in Crohn’s disease patientsECCO '16 Amsterdam
2016
P151: Ulcerative colitis patients with zinc deficiency are at higher risk for disease-related complicationsECCO '16 Amsterdam
2016
P152: Faecal calprotectin 100 ug/g and 50 ug/g predict endoscopic and histologic remission: a prospective study in quiescent ulcerative colitisECCO '16 Amsterdam
2016
P153: Type of treating physician is associated with long-term disease outcome in the prospective Belgian paediatric Crohn’s disease registryECCO '16 Amsterdam
2016
P154: Temporal relationship of pregnancy to long-term disease course and pregnancy and foetal outcomes: North Indian inflammatory bowel disease cohort studyECCO '16 Amsterdam
2016